Hearing Health & Technology Matters

Fennec Pharmaceuticals reported continued growth in demand for PEDMARK® (sodium thiosulfate), its treatment designed to reduce the risk of hearing loss associated with cisplatin chemotherapy, as new clinical evidence adds support for protecting hearing without compromising cisplatin’s ...

Oticon has introduced Oticon Reveal, a new hearing aid platform featuring what the company describes as the world’s first Dual AI system for hearing aids.

The new platform uses two dedicated AI systems—one focused on speech and another on contextual sounds—with the goal of providing clearer speech while preserving meaningful sounds in the surrounding environment. Otico...

Is this you? On the surface, you appear to have this hearing loss thing nailed. You wear the technology, you self-identify without shame, and in 30 seconds flat, you can rearrange a room and group of people to your hearing and speechreading advantage! Yet, day after day, aspects of hearing loss make you mad.

If so, you’re not alone. For everyone, comm...

Samsung Electronics announced that its Galaxy Buds Hearing Aid feature has received clearance from the U.S. Food and Drug Administration (FDA), allowing compatible Galaxy Buds1 to function as over-the-counter (OTC) hearing aids2 for adults age 18 and older with perceived mild to moderate hearing loss.

The feature is designed for users who may have difficulty following ...

CAMBRIDGE, MASSACHUSSETTS — Skylark Bio, a clinical-stage biotechnology company developing targeted genetic medicines for hearing loss and other monogenic disorders, announced that the first patient has been dosed in the SONIX Phase 1/2 clinical trial evaluating SKY-GJB2, the company’s investigational inner-ear-targeted gene therapy for GJB2-mediated hearing loss.